1 / 6

Aoxing Pharmaceutical AMEX: AXN

Aoxing Pharmaceutical AMEX: AXN. Transaction Overview Financing and Listing . Primary Capital LLC 80 Wall Street, 5th Floor New York, NY 10005. All financial information as of August, 2010 . Corporate Overview.

laban
Download Presentation

Aoxing Pharmaceutical AMEX: AXN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Aoxing PharmaceuticalAMEX: AXN Transaction Overview Financing and Listing Primary Capital LLC80 Wall Street, 5th FloorNew York, NY 10005 All financial information as of August, 2010

  2. Corporate Overview • Specialize in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. • Headquartered in Shijiazhuang City, outside Beijing, Aoxing has the largest and most advanced manufacturing facility for highly regulated narcotic medicines.  • Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the China State Food and Drug Administration (SFDA).  • Strategic alliance partnerships with Johnson Matthey Plc (LSE: JMAT), QRxPharma (ASX: QRX) and American Oriental Bioengineering, Inc (NYSE: AOB).  All financial information as of August, 2010

  3. Key Accomplishments July 2010:NYSE AMEX listing (AXN) June 2009: Financing - $5,000,000 (common stock) April 2008: Financing - $18,000,000 (30,000,000 shares of common stock to American Oriental Bioengineering, Inc.(“AOB”)) Sep 2006:Financing - $2,116,000 (common share and warrants) Apr 2006:Reverse Merger on OTC.BB, ticker CAXG All financial information as of August, 2010

  4. Financials Expressed in USD Millions All financial information as of August, 2010

  5. Primary’s Value Added Services • Originated transaction and managed reverse merger • Principal Investor and placement agent • Prepared Business Plan, Financial Model & PPT • Assisted with legal and business due diligence • Managed all pre-audit financial work • John Leo served as Corporate Secretary and Director • Identified and recruited other board members • Engaged IR/PR firm for aftermarket support • Remained active in aftermarket activity with IR/PR • Assisted with AMEX listing process All financial information as of August, 2010

  6. Contact New York Primary Capital LLC 80 Wall Street, 5thFloor New York, NY 10005 1-212-300-0060 California 131 East Fig Street Fallbrook, CA USA 92028 1-760-723-4900 Shanghai Huachen Financial Mansion, room 704, 900 Pudong Ave., Pudong, Shanghai, PRC 200135 86-21-5852-9391 All financial information as of August, 2010

More Related